Evidence map›Paper›PMID 26389021›Full record

ArticleSpringerPlus2015

Transient transgenesis of the tapeworm Taenia crassiceps.

Bárbara Moguel, Norma Moreno-Mendoza, Raúl J Bobes, Julio C Carrero, Jesús Chimal-Monroy, Martha E Díaz-Hernández, Luis Herrera-Estrella, Juan P Laclette

Open access · diamondAbstract read
In one paragraph

Article in SpringerPlus, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The Genomes of Two Strains ofFrontiers in cellular and infection microbiology · 2022
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bárbara MoguelInstitute for Biomedical Research, Universidad Nacional Autónoma de México, Av. Universidad 3000, Coyoacán, C.P. 04510 México DF, México.
Norma Moreno-MendozaInstitute for Biomedical Research, Universidad Nacional Autónoma de México, Av. Universidad 3000, Coyoacán, C.P. 04510 México DF, México.
Raúl J BobesInstitute for Biomedical Research, Universidad Nacional Autónoma de México, Av. Universidad 3000, Coyoacán, C.P. 04510 México DF, México.
Julio C CarreroInstitute for Biomedical Research, Universidad Nacional Autónoma de México, Av. Universidad 3000, Coyoacán, C.P. 04510 México DF, México.
Jesús Chimal-MonroyInstitute for Biomedical Research, Universidad Nacional Autónoma de México, Av. Universidad 3000, Coyoacán, C.P. 04510 México DF, México.
Martha E Díaz-HernándezInstitute for Biomedical Research, Universidad Nacional Autónoma de México, Av. Universidad 3000, Coyoacán, C.P. 04510 México DF, México.
Luis Herrera-EstrellaNational Laboratory of Genomics for Biodiversity-cinvestav, Km 9.6 Libramiento Norte Carretera Irapuato-León, C.P. 36821 Irapuato, Gto México.
Juan P LacletteInstitute for Biomedical Research, Universidad Nacional Autónoma de México, Av. Universidad 3000, Coyoacán, C.P. 04510 México DF, México.
Universidad Nacional Autónoma de México · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human and porcine cysticercosis is caused by the larval stage of the flatworm Taenia solium (Cestoda). Infestation of the human brain, also known as neurocysticercosis, is the most common parasite disease of the central nervous system worldwide. Significant advances in the understanding of the disease have been achieved using the Taenia crassiceps murine model. We describe here a successful transfection protocol of T. crassiceps cysticerci as the first step to approach a number of currently inaccessible biological questions on cysticercosis. T. crassiceps cysticerci (ORF strain) were microinjected with the plasmid pcDNA3.1/NT-GFP-TOPO, encoding the green fluorescent protein (GFP) driven by a cytomegalovirus promoter (CMV). Twelve hours after the microinjection, GFP fluorescence gradually developed in patches associated to bud structures in the bladder wall of cysts. Fluorescence reached a peak at 24-48 h and lasted up to 72 h after the microinjection. Immunohistochemical studies on tissue sections of transfected cysts using an anti-GFP antibody, demonstrated co-localization of the antibody and the GFP fluorescence in the tegumentary cytoplasm and subtegumentary cytons. To validate at the mRNA level the expression of GFP, we carried out RT-PCR using two pairs of nested primers. Results showed expression of GFP-mRNA at 24 h post-transfection. Moreover, western blot assays of crude extracts of transfected cysts, carried out using the anti-GFP specific antibody, showed the expected protein band of 27 kDa, demonstrating that the GFP expression started at 24 after plasmid microinjection and was maintained up to 72 h. These findings will facilitate the development of functional genomics approaches applied to this model of cysticercosis.

Indexed as

CysticerciCytomegalovirus promoterGreen fluorescent proteinTaenia crassicepsTaenia soliumTransfection

Identifiers

PMID26389021
PMCPMC4571025
OpenAlexW1845751502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.